Grant Pickering - Mar 1, 2023 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role: Chief Executive Officer, Director
Signature: Grant Pickering, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol: PCVX
Transactions as of: Mar 1, 2023
Transactions value $: -$128,578
Form type: 4
Date filed: 3/3/2023, 04:09 PM
Previous filing: Jan 4, 2023
Next filing: Mar 31, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCVX	Common Stock	Award	$0	+53.9K	+14.39%	$0.00	428K	Mar 1, 2023	Direct	F1
transaction	PCVX	Common Stock	Tax liability	-$129K	-3.1K	-0.72%	$41.49	425K	Mar 2, 2023	Direct	F2
holding	PCVX	Common Stock						158K	Mar 1, 2023	By Children's Trust	F3
holding	PCVX	Common Stock						158K	Mar 1, 2023	By Children's Trust	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCVX	Stock Option (right to buy)	Award	$0	+323K		$0.00	323K	Mar 1, 2023	Common Stock	323K	$41.67	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 2, 2023 and 12.5% of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.
F2	Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units.
F3	Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
F4	Shares are held directly by a trust for the benefit of the Reporting Person's son.
F5	1/48 of shares subject to the option vest on April 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.